Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders

Julian Martinez-Mayer1, Maria Ines Perez-Millan1

  • 1Instituto de Biociencia, Biotecnología y Biología Traslacional (iB3), Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.

Frontiers in Endocrinology
|February 27, 2023
PubMed

Insights

Prokineticin receptor 2 (PROKR2) gene variants cause hypogonadotropic hypogonadism and Kallmann Syndrome. New research links PROKR2 to pituitary disorders, expanding its disease spectrum.

Area of Science:

  • Endocrinology
  • Genetics
  • Neuroscience

Background:

  • Prokineticin receptor 2 (PROKR2) is a G-protein-coupled receptor binding PROK1 and PROK2.
  • PROKR2 mutations are linked to hypogonadotropic hypogonadism, anosmia/hyposmia, and Kallmann Syndrome.
  • Recent findings associate PROKR2 variants with diverse endocrine and pituitary disorders.

Purpose of the Study:

  • To review the evolving understanding of PROKR2-related diseases.
  • To catalog reported PROKR2 variants and discuss their origins.
  • To analyze the classification and functional impact of PROKR2 variants.

Main Methods:

  • Literature review of PROKR2-related disease.
  • Analysis of reported PROKR2 variants.
  • Discussion of variant classification and functional assessments.

Main Results:

  • PROKR2 mutations cause hypogonadotropic hypogonadism, Kallmann Syndrome, and olfactory deficits.
  • PROKR2 variants are increasingly linked to pituitary disorders, including growth hormone deficiency and septo-optic dysplasia.
  • A comprehensive overview of PROKR2 variants, their origins, and functional implications is presented.

Conclusions:

  • PROKR2 plays a critical role in neuroendocrine development and function.
  • Understanding PROKR2 variants is crucial for diagnosing and managing a spectrum of endocrine and developmental disorders.
  • Further research into PROKR2 function will elucidate its broader role in human health.